Emergency Blood and Massive Transfusion: The Surgeon s Perspective. Transfusion Medicine Update September 16 17, 2009

Similar documents
Introduction to coagulation and laboratory tests

Prothrombin Complex Concentrate- Octaplex. Octaplex

3/16/15. Management of the Bleeding Trauma Patient: Concepts in Damage Control Resuscitation. Obligatory Traumatologist Slide

The principle of 1:1:1 blood product use in the resuscitation of trauma victims. K. D. Boffard

Recombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD

Pediatric massive transfusion protocols

Massive transfusion: Recent advances, guidelines & strategies. Dr.A.Surekha Devi Head, Dept. of Transfusion Medicine Global Hospital Hyderabad

Primary Exam Physiology lecture 5. Haemostasis

Epidemiology. Case. Pre-Hospital SI and Massive Transfusion

Management of the Trauma Patient. Elizabeth R Benjamin MD PhD Trauma and Surgical Critical Care Critical Care Symposium April 20, 2015

Bleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon

Damage Control Resuscitation. VGH Trauma Rounds 2018 Harvey Hawes

Blood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )

The changing face of massive transfusion

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY

Review of the TICH-2 Trial

Hemostatic Resuscitation

Transfusion Requirements and Management in Trauma RACHEL JACK

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient

WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION

Blood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.

Define Shock, mostly as it relates to bleeding Options and evidence for tools of resuscitation Understand a little about coagulation and coagulopathy

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

Major Haemorrhage Protocol. Commentary

Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

Adult Trauma Advances in Pediatrics. (sometimes they are little adults) FAST examination. Who is bleeding? How much and what kind of TXA volume?

Diagnosis of hypercoagulability is by. Molecular markers

3/19/2012. What is the indication for anticoagulation? Has the patient previously been on warfarin? If so, what % of the time was the INR therapeutic?

Adult Reversal of Anticoagulation and Anti-platelet Agents for Life- Threatening Bleeding or Emergency Surgery Protocol

TRAUMA RESUSCITATION. Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital

4/23/2009. September 15, 2008

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

ACQUIRED COAGULATION ABNORMALITIES

Part IV Antithrombotics, Anticoagulants and Fibrinolytics

True/False: Idarucizumab can be utilized for the management of bleeding associated with dabigatran.

Chapter 1 Introduction

Hemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot

Kay Barrera MD. Surgery Grand Rounds June 19, 2014 SUNY Downstate

Coagulation, Haemostasis and interpretation of Coagulation tests

Discuss the role of idarucizumab for the management of bleeding associated with dabigatran

ADMINISTRATIVE CLINICAL Page 1 of 6

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference

Coagulopathy: Measuring and Management. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine

Hemostatic Resuscitation in Trauma. Joanna Davidson, MD 6/6/2012

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

HYPOTHERMIA IN TRAUMA. Kevin Palmer EMT-P, DiMM

Shock and Resuscitation: Part II. Patrick M Reilly MD FACS Professor of Surgery

Recombinant factor VIIa: Hype or hope? Jed Gorlin MD, MBA

Thicker than Water. Alisa McQueen MD, FAAP, FACEP Associate Professor of Pediatrics The University of Chicago

2 Liters. Goal: Basic Algorithm Volume Resuscitation in Trauma. Initial Fluids. Blood. Where do Blood Products Come From?

2/12/2018 TOURNIQUETS, FROM THE BATTLEFIELD TO YOUR BACKYARD Trauma Symposium RICHARD KING, MD, FACEP 01/26/2018 WARNING

UNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD

Damage Control Resuscitation

Resuscitation Update

Remote Damage Control Resuscitation: An Overview for Medical Directors and Supervisors. THOR Collaboration

CrackCast Episode 7 Blood and Blood Components

Financial Disclosure. Objectives 9/24/2018

EMSS17: Bleeding patients course material

Does a Controlled Fluid Resuscitation Strategy Decrease Mortality in Trauma Patients?

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY

Inherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD

This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion

Reversal of Novel Oral Anticoagulants. Angelina The, MD March 22, 2016

Implementation and execution of civilian RDCR programs Minnesota RDCR

Clinical Overview of Coagulation Testing Issues

10/4/2018. Nothing to Disclose. Liz Robertson, MD FACS October 5, 2018 Steven R. Hall Trauma Symposium Big Cedar Lodge, MO

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

TRANSFUSIONS FIRST, DO NO HARM

BLOOD IN THE AIR: THE STARS EXPERIENCE Dr. Ryan Deedo MD DipAeroRT FRCPC Transport Physician STARS Medical Communications Lead (Calgary)

Michael Avant, M.D. The Children s Hospital of GHS

Agent Dose MoA/PK/Admin Adverse events Disadvantages Protamine Heparin: 1mg neutralizes ~ 100 units Heparin neutralization in ~ 5 min

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph

Hematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway

TXA. Things Change. Tranexamic Acid TXA. Resuscitation 2017 TXA In The ED March 31, MAST Trousers. High Flow IV Fluids.

Biochemical Reaction Networks and Blood Clotting

M.A.R.C.H. M.A.R.C.H. 10/11/2017. Hartford Consensus 2 April Comparison of Statistics for Battle Casualties,

Massive Transfusion Initiation & Implication

Sign up to receive ATOTW weekly

New Age Anticoagulants: Bleeding Considerations

High Risk + Challenging Trauma Cases. Hawaii. Topics 1/27/2014. David Thompson, MD, MPH. Head injury in the anticoagulated patient.

12/29/2014. IV/IO Therapy & Fluid Administration. Objectives. Cleansing of the soul

Managing Bleeding in the Patient on DOACs

Approach to disseminated intravascular coagulation

The LaboratoryMatters

Blood. Biol 105 Lecture 14 Chapter 11

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013

Recombinant Factor VIIa for Intracerebral Hemorrhage

Platelet-fibrin clot. 50Kd STEMI. Abciximab. Video of a IIb/IIIa inhibitor in action. Unstable Angina and non-stsegment

Coagulopathy Case - 3. Andy Nguyen, M.D. 2009

Recombinant Treatments for Bleeding Disorders. An overview of treatments that are considered to have a low risk of viral transmission

Management of Pelvic Fracture

PUZZLE. EARLY IMPACT ALS Jamie Syrett, MD Director of Prehospital Care Rochester General Health System PUZZLE THINKING OUTSIDE THE BOX! EARLY IMPACT?

VENOUS THROMBOEMBOLISM PHARMACOLOGY. University of Hawai i Hilo DNP Program NURS 603 Advanced Clinical Pharmacology Danita Narciso Pharm D

4/5/17. Blood. Blood. Outline. Blood: An Overview. Functions of Blood

Kristan Staudenmayer, MD Stanford University, Stanford, CA

RESUSCITATION IN TRAUMA. Important things I have learnt

Transcription:

Transfusion Medicine Update September 16 17, 2009 Mandip S. Atwal, D.O. FACOS Carl M. Pesta, D.O. FACOS

Agenda History Hemorrhagic shock Transfusion is Bad Transfusion Prevention Transfusion The Red Chest Concept Why your hospital should have The Red Chest and a Massive Transfusion Protocol

Agenda

Agenda

Agenda

History 1628 William Harvey M.D. published An Anatomical Study of the Motion of the Heart and of the Blood in Animals, described the circulation of blood 1655 Richard Lower M.D. transfuses blood between dogs in England, keeps dogs alive 1818 James Blundell M.D. transfused blood to treat postpartum hemorrhage (donor was husband) 1937 Bernard Fantus M.D., Cook County, established first blood bank 1994 Bickell M.D. Immediate versus delayed fluid resuscitation for Hypotensive patients with penetrating torso injuries 2003 Kenneth Mattox M.D. Permissive Hypotension

Hemorrhagic shock

Hemorrhagic shock

The Surgeons Perspective Hemorrhagic shock

Hemorrhagic shock

Hemorrhagic shock Hemorrhage is the most common cause of shock in the trauma patient Hemorrhage is defined as an acute loss of circulating blood volume ATLS. American College of Surgeons. Chicago, 1997. p 93

Hemorrhagic shock Massive transfusion may be defined as the replacement of 50% or more a patients blood volume in 12 to 24 hours Collins, JA. Problems associated with the massive transfusion of stored blood. Surgery 1974; 75:274.

Hemorrhagic shock

Hemorrhagic shock

Hemorrhagic shock Based on Ideal body weight a 70kg male has a circulating blood of 5 liters, about 7% of body weight Blood volume for a child is calculated as 8% to 9% of the body weight (80 to 90cc/kg) How much volume loss causes shock? Class I (donate a pint of blood) Class II (uncomplicated but you need crystalloids) Class III (Blood will be required) Class IV (Death is pending) ATLS. American College of Surgeons. Chicago, 1997. p 93

Hemorrhagic shock Class I Class II Class III Class IV Blood loss 750 or less 750 1500 1500 2000 2000 % Blood Vol < 15 15 30 30-40 40 % Blood Vol < 100 > 100 120 > 140 Blood Pressure Normal Normal Decreased Decreased Pulse Pressure Normal or Inc Decreased Decreased Decreased Respiratory Rate 14 20 20-30 30-40 > 35 Urine output cc/hr 30 20-30 5 15 Negligible CNS/Mental Slightly Anxious Mildly Anxious Anxious Confused Confused lethargic Fluid replacement Crystalloid Crystalloid Crystalloid/blood Crystalloid/blood 3:1 rule Yes Yes Yes Yes ATLS. American College of Surgeons. Chicago, 1997. p 98

Hemorrhagic shock R. Adams Cowely M.D. There is a golden hour between life and death. If you are critically injured you have less than 60 minutes to survive. You might die right then; it may be three days or two weeks later but something has happened in your body that is irreparable French World War I data, mortality from wound and treatment 1 hr 10% 2 hr 20% 3 hr 12% 4hr 33% 5 hr 36% 6 hr 41% 8 hr 75% 10hr 75% Santy, P. Marquis Moulinier, Da Shock Tramatique dans les blessures de Guerre, Analysis d'observations. Bull. Med. Soc. Chir., 1918, 44:205 1918

Hemorrhagic shock Experience has taught me often the Golden hour is Golden minutes and may be Golden seconds in our city of Detroit Need blood now Need to control blood loss now

Hemorrhagic shock

Hemorrhagic shock

Hemorrhagic shock

Hemorrhagic shock

Hemorrhagic shock

Transfusion is bad What we know and is fact Increased Acute lung Injury Increased Renal Failure Increased Coagulopathy Increased Infections Increased Volume overload Decreased Oxygen affinity

Transfusion is bad

Transfusion is bad

Transfusion is bad

Transfusion is bad

Transfusion Prevention Factor VIIa Initial FDA approval was for Hemophilia. Hemophilia is a failure of platelet surface thrombin generation Recombinant factor 7a, Man made protein, replicated human activated factor VII. The Golden Bullet?

Human FVII gene hfvii Gene Single copy of gene isolated Amplification Multiple copies of hfvii gene Incorporate into BHK cells hfvii gene Fermentation of BHK cells BHK cells hfvii = human factor VII BHK = baby hamster kidney

Transfusion Prevention Factor VIIa, how does it work? Tissue factor (TF) is a membrane bound glycoprotein expressed on cells in the sub endothelium. Any tissue injury that disrupts the endothelium allows TF to enter circulation.

Transfusion Prevention Factor VIIa, how does it work? TF is a high affinity receptor for rfviia The TF/rfVIIa compound directly catalyzes the conversion of factor X to Xa.

Transfusion Prevention Factor VIIa, how does it work? Xa facilitates conversion of prothrombin (II) to thrombin (IIa) Thrombin aids in the conversion of fibrinogen (I) to fibrin (Ia). Accumulation of fibrin into the aggregating platelets results in the formation of the primary platelet plug.

XII XIIa APTT TF VII VIIA XI XIa IX IXa X Xa VIIIa VIII Va V PT II IIa I Ia THROMBIN TIME

Transfusion Prevention Factor VIIa, does it work? Multiple citations in the literature demonstrating efficacy in hemophilia as approved by the FDA. Multiple citations in the literature citing increased survival and decreased use of blood transfusions.

Transfusion Prevention Factor VIIa, Limitations 1.2 mg vial $1200 4.8 mg vial $4000

Transfusion Prevention Lessons from Gulf War one and two

Transfusion Prevention Lessons from Gulf War one and two FFP High ratio of FFP to PRBC increases survival 246 patients at Army Combat hospital in Iraq FFP: PRBC (1:1.4) 81% survival rate FFP: PRBC (1:2.5) 66% survival rate FFP: PRBC (1:8) 35 % survival rate

Transfusion Prevention Lessons from Gulf War one and two Hypotension

Transfusion Prevention Lessons from Gulf War one and two Hypotension We all recall the adrenalin rush in the field or emergency center resuscitation of the post traumatic hypotensive patient. We raise the blood pressure with the "treatment de jour" and get the patient to the operating room or ICU, only to face a complication or death later. We swell with pride as we brag that the patient was normotensive when he/she left our care. For decades, we have refused to even question whether or not our aggressive hyper resuscitation contributed to that death or complication. Ken L. Mattox, trauma.org 8:1, January 2003 Permissive Hypotension

Transfusion Prevention Lessons from Gulf War one and two Hypotension Ken Mattox M.D. Permissive hypotension Pop the clot

Transfusion Prevention Lessons from Gulf War one and two Hypotension Ken Mattox M.D. Pop the clot occurs at systolic of 80

Transfusion Prevention Lessons from Gulf War one and two Topical dressings

Transfusion Prevention Lessons from Gulf War one and two Topical dressings Quick Clot Absorbs water from blood, leaving concentrate of clotting factors over site if injury HemCon Made from chitosan (+charge) and bonds with RBC (- charge) and a seal results over the injury

Transfusion Prevention

Transfusion Prevention

Transfusion Prevention Lessons from Gulf War one and two Tourniquets Control bleeding Reducing transfusion requirements Saving life

Transfusion Prevention Lessons from Gulf War one and two Tourniquets

Transfusion Prevention Lessons from Gulf War one and two Tourniquets

Transfusion The Red Chest Concept Systemic hypotension Systemic hypotension is a late marker of shock after trauma Need Blood and need it quick Parks, JK. Systemic hypotension is a late marker of shock after trauma. Am J Surgery. 2006: 192: 710-721

Transfusion The Red Chest Concept Systemic hypotension Shock is a common and frequent treatable cause of death in injured patients and is second leading cause if death in trauma patients (TBI is number one) ATLS. American College of Surgeons. Chicago, 1997

Transfusion The Red Chest Concept Massive transfusion protocol

Transfusion The Red Chest Concept Massive transfusion protocol Red Chest 1 4 units PRBC O neg, 2 Units Thawed Plasma Red Chest 2 Repeat Red Chest I or 4u type specific and 2 units Thawed Plasma Red Chest 3 4u type specific, 2 units Thawed, 10U platelets and 5 Cryo

Transfusion The Red Chest Concept Massive transfusion protocol Red Chest 4 4u type specific and 2 Units Thawed Plasma Red Chest 5 4u type specific and 2 units Thawed Plasma Red Chest 6 4u type specific, 2 units Thawed, 10U platelets and 5 Cryo

Transfusion The Red Chest Concept Massive transfusion protocol Red Chest 7 Revert to red chest 4 and repeat red chest 4, 5, 6

END, QUESTIONS?